Table 4.
Correlations Between Plasma Adiponectin Concentration and Established Cardiovascular Risk Markers
| Men (n =1653) | Women (n =1777) | |||
|---|---|---|---|---|
| r | P Value | r | P Value | |
| Age | 0.081 | 0.001 | 0.065 | 0.006 |
| SBP | −0.083 | 0.001 | −0.152 | <0.001 |
| DBP | −0.104 | <0.001 | −0.135 | <0.001 |
| Body mass index | −0.188 | <0.001 | −0.311 | <0.001 |
| LDL-C | 0.12 | <0.001 | 0.194 | <0.001 |
| HDL-C | 0.206 | <0.001 | 0.323 | <0.001 |
| Triglycerides | −0.171 | <0.001 | −0.285 | <0.001 |
| Creatinine | −0.084 | 0.001 | −0.095 | <0.001 |
| C-reactive protein | −0.062 | 0.012 | −0.159 | <0.001 |
| Fasting glucose | −0.255 | <0.001 | −0.36 | <0.001 |
| Type 2 diabetes mellitus | −0.192 | <0.001 | −0.257 | <0.001 |
| Current smoking | −0.036 | 0.142 | −0.055 | 0.021 |
| MDS1 | −0.246 | <0.001 | −0.324 | <0.001 |
| MDS2 | −0.114 | <0.001 | 0.005 | 0.846 |
| MDS3 | 0.038 | 0.120 | −0.078 | 0.001 |
Values are Spearman rank correlation coefficients. DBP indicates diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MDS, multidimensional scaling component; SBP, systolic blood pressure.